Kalb Vs. NSF: A Matter Of Deception--Or Sour Grapes?

[Editor’s note: In December 1987, geologist Jon Kalb received an apology and $20,000 from the National Science Foundation after agency officials acknowledged that an NSF peer review panel had discussed a false rumor that KaIb was working for the CIA while conducting research in Ethiopia. The incident, which took place during a review of an application that KaIb had submitted in 1976, led Kalb to question many aspects of the agency’s peer review system. In July, Kalb—with the h

Written byJon Kalb
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

[Editor’s note: In December 1987, geologist Jon Kalb received an apology and $20,000 from the National Science Foundation after agency officials acknowledged that an NSF peer review panel had discussed a false rumor that KaIb was working for the CIA while conducting research in Ethiopia. The incident, which took place during a review of an application that KaIb had submitted in 1976, led Kalb to question many aspects of the agency’s peer review system. In July, Kalb—with the help of attorney Eric Glitzenstein—submitted to NSF a 37-page petition pushing for reforms of the system that Kalb sees as necessary if other scientists are to be assured of receiving fair and unbiased treatment from NSF. Among other things, KaIb charges that NSF maintains a secret filing system and systematically deprives applicants of their right to know of all reviewer comments and discussions considered in connection with their proposals.

According to Jim ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies